Catalent Regains Compliance with NYSE Continued Listing Standards
13 Juni 2023 - 10:53PM
Business Wire
Catalent, Inc. (“Catalent” or the “Company”) (NYSE: CTLT)
announced today that the Company has received written notification
(“Notice”) from the New York Stock Exchange (“NYSE”) that it has
officially regained compliance with the NYSE continued listing
standards.
Following the filing by the Company on June 12, 2023 of its
Quarterly Report on Form 10-Q for the three and nine months ended
March 31, 2023, the NYSE’s Notice cured Catalent of the previously
disclosed non-compliance with exchange listing requirements under
the timely filing criteria established in Section 802.01E of the
NYSE Listed Company Manual and removed the Company from the
noncompliant issuers list on the NYSE website at www.nyse.com.
About Catalent
Catalent, Inc. (NYSE: CTLT), an S&P 500® company, is the
global leader in enabling pharma, biotech, and consumer health
partners to optimize product development, launch, and full
life-cycle supply for patients around the world. With broad and
deep scale and expertise in development sciences, delivery
technologies, and multi-modality manufacturing, Catalent is a
preferred industry partner for personalized medicines, consumer
health brand extensions, and blockbuster drugs. Catalent helps
accelerate over 1,000 partner programs and launch over 150 new
products every year. Its flexible manufacturing platforms at over
50 global sites supply around 80 billion doses of nearly 8,000
products annually. Catalent’s expert workforce of approximately
18,000 includes more than 3,000 scientists and technicians.
Headquartered in Somerset, New Jersey, the company generated nearly
$5 billion in revenue in its 2022 fiscal year. For more information
visit www.catalent.com.
Forward Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. All statements contained in this press release that do not
relate to matters of historical fact should be considered
forward-looking statements, including without limitation with
respect to the Company’s compliance with the continued listing
requirements of the NYSE listing standards. These forward-looking
statements are based on management’s current expectations. These
statements are neither promises nor guarantees, but involve known
and unknown risks, uncertainties and other important factors that
may cause actual future events, results or achievements to be
materially different from the Company’s expectations and
projections expressed or implied by the forward-looking statements.
Important factors include, but are not limited to, those discussed
under the caption “Risk Factors” in the Company’s Annual Report on
Form 10-K for the year ended June 30, 2022 (as amended), the
Company’s Quarterly Report on Form 10-Q for the three and nine
months ended March 31, 2023, and the Company’s other filings with
the SEC. Forward-looking statements speak only as of the date of
this press release and are based on information available to the
Company as of the date of this press release, and the Company
assumes no obligation to update such forward-looking statements,
whether as a result of new information, future events or otherwise,
except as required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230613727059/en/
Investor Contact: Paul Surdez, Catalent, Inc. (732) 537-6325
investors@catalent.com
Media Contact: Chris Halling +44 (0)7580 041073
media@catalent.com
Catalent (NYSE:CTLT)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Catalent (NYSE:CTLT)
Historical Stock Chart
Von Jul 2023 bis Jul 2024